Search Results

Outdated insurance benefit designs continue to cover oral medications under the pharmacy benefit, which often mean high, burdensome out-of-pocket costs for patients.

Understanding the magnitude and underlying considerations surrounding the multidimensional and controversial issue of cancer drug parity is important for evaluating the value of cancer treatments and the impact of related legislative efforts.